Cardiovascular

Immunothrombosis Biomarkers and Multi-Omics Profiles After Successful Recanalization in Patients Receiving Ischemic Postconditioning: An Exploratory Analysis of the INSPIRE Trial.

TL;DR

In this exploratory, hypothesis-generating analysis of the INSPIRE trial, ischemic postconditioning after successful recanalization was associated with lower neutrophil activation, slower clot propagation, and faster microvascular transit, and multi-omics profiling pointed to blood-brain barrier integrity and mitochondrial bioenergetics as candidate pathways.

Key Findings

Patients receiving ischemic postconditioning (IPostC) had lower neutrophil CD11b expression in arterial blood drawn about 15 minutes after successful recanalization than controls.

  • Median neutrophil CD11b was 52.15 versus 64.27 mean fluorescence intensity ×10² (P = 0.011).
  • Arterial blood was analyzed by flow cytometry about 15 min after successful recanalization.
  • The analysis included all 60 randomized patients.
  • Biomarker comparisons were not adjusted for multiple comparisons.

IPostC was associated with a lower thromboelastography α-angle, indicating slower clot propagation.

  • Median α-angle was 65.15° versus 67.95° in controls (P = 0.037).
  • Thromboelastography was performed on arterial blood obtained about 15 min after recanalization.
  • The comparison was not adjusted for multiple testing.

IPostC was associated with shorter quantitative DSA-derived microcirculation time, indicating faster microvascular transit.

  • Median microcirculation time was 2.11 versus 3.03 s (P = 0.020).
  • This analysis included 55 patients with usable quantitative DSA data.
  • Metrics were obtained after successful recanalization.

Longer microcirculation time correlated with greater infarct growth.

  • Correlation was r = 0.533 (P < 0.001).
  • Infarct growth was measured from baseline to 48 h.
  • This links the microvascular transit measure to the parent trial's primary imaging outcome.

Plasma proteomic and metabolomic profiling identified signals involving blood-brain barrier and extracellular-matrix organization and mitochondrial bioenergetics.

  • Omics profiling was performed in 29 patients.
  • These pathways were proposed as candidate mechanisms of IPostC's effect.
  • The findings are exploratory and hypothesis-generating.

Few omics signals survived false discovery rate correction.

  • No protein remained significant after FDR correction.
  • 17 metabolites remained significant after FDR correction.
  • Biomarker comparisons overall were not adjusted for multiple comparisons.

The parent INSPIRE trial delivered IPostC in situ as four cycles of 2-minute balloon inflation and 2-minute deflation at the previously occluded arterial segment immediately after successful recanalization, and it reduced infarct growth from baseline to 48 h.

  • The present analysis is an exploratory secondary analysis of all 60 randomized patients.
  • Trial registration: NCT06545734, registered 9 August 2024.

What This Means

After a stroke caused by a blocked brain artery, doctors can remove the clot with a catheter, but reopening the vessel doesn't always restore blood flow in the tiny vessels of the brain. In the INSPIRE trial, a technique called ischemic postconditioning, in which a balloon is briefly inflated and deflated four times at the spot of the former blockage right after the clot is removed, reduced how much the stroke damage grew over 48 hours. This follow-up analysis examined blood and imaging measures to look for how it might work. Patients who received the technique had lower activation of neutrophils (an inflammatory white blood cell), slower clot-forming activity on a blood clotting test, and faster blood transit through small brain vessels on angiography. Slower transit through the small vessels was linked to larger growth of stroke damage. Protein and metabolite profiling in a smaller group of 29 patients hinted that the blood-brain barrier and the energy-producing machinery of cells (mitochondria) might be involved. These results are preliminary. The study was small, many comparisons were not corrected for chance findings, and in the omics analysis no proteins and only 17 metabolites held up after correction. This research suggests possible mechanisms worth testing, but larger studies are needed to confirm them.

Have a question about this study?

Citation

Xu Y, Lu D, Liu S, Jiang X, Wang Q, Luo L, et al.. (2026). Immunothrombosis Biomarkers and Multi-Omics Profiles After Successful Recanalization in Patients Receiving Ischemic Postconditioning: An Exploratory Analysis of the INSPIRE Trial.. Translational stroke research. https://doi.org/10.1007/s12975-026-01513-x